News
Cathie Wood’s ARK Invest has offloaded more than $96 million worth of Circle shares in just two days, marking a sharp ...
Here’s why investors with a high risk appetite can consider gaining exposure to disruptive exchange-traded funds ETFs such as ...
Ark Invest, in collaboration with consulting firm Mach33, forecast that SpaceX could reach an enterprise value of $2.5 ...
ARK’s moves reflect the high-stakes nature of early post-IPO trading in volatile sectors like crypto. Wood has maintained her long-term bullish stance on digital assets — most notably predicting that ...
ARK values SpaceX at 18 times 2030 Ebitda. For context, GE Aerospace is valued at about 29 times estimated 2025 Ebitda. Its ...
Corporate America is regaining its appetite for risk as expectations build around Donald Trump’s push for deregulation and ...
ARK dumped another 300,108 Circle shares from its three funds for $44.7 million on June 17, with CRCL tumbling to $149.
Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the ...
Warren Buffett, Cathie Wood, and Bill Ackman are three powerhouse investors who each have a different approach to investing.
SpaceX will eventually go “all in” on Elon Musk’s goal of colonizing Mars, according to the firm of famed tech investor ...
ARK Invest has trimmed its Circle stake after a 387% post-IPO rally, selling shares as stablecoin adoption gains momentum.
Another notable buy was in Beam Therapeutics Inc (NASDAQ: BEAM ), a biotechnology company specializing in precision genetic medicines. ARK’s ARKK ETF purchased 349,264 shares, adding $6,314,693 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results